Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

AIM: To evaluates the effectiveness and safety of the first generation, NS3/4A protease inhibitors (PIs) in clinical practice against chronic C virus, especially in patients with advanced fibrosis. METHODS: Prospective study and non-experimental analysis of a multicentre cohort of 38 Spanish hospita...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Salmerón, Javier, Vinaixa, Carmen, Berenguer, Rubén, Pascasio, Juan Manuel, Sánchez Ruano, Juan José, Serra, Miguel Ángel, Gila, Ana, Diago, Moisés, Romero-Gómez, Manuel, Navarro, José María, Testillano, Milagros, Fernández, Conrado, Espinosa, Dolores, Carmona, Isabel, Pons, José Antonio, Jorquera, Francisco, Rodriguez, Francisco Javier, Pérez, Ramón, Montero, José Luis, Granados, Rafael, Fernández, Miguel, Martín, Ana Belén, Muñoz de Rueda, Paloma, Quiles, Rosa
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2015
Assuntos:
Prospective Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533049/
https://ncbi.nlm.nih.gov/pubmed/26290644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i30.9163
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados